Heptapeptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-04-02. Where a claim depends on a specific study, the study is described rather than over-claimed.
Early published reports described melanotan-2 as a tanning agent without sun protection, which means darkening is not the same as protection against ultraviolet radiation. Later studies explored the peptide in erectile dysfunction, hemorrhagic shock, and some skin conditions. No regulator in the United States or Europe has approved it for clinical use. Many products labelled melanotan-2 are sold without approval and their identity and purity are unverified. Its long-term safety in humans remains an open question.
Melanotan-2, also written Melanotan II, is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, and the lactam bridge between the aspartate and lysine side chains constrains the peptide into a ring. This structural change increases receptor affinity and metabolic stability relative to the native hormone. The compound was created in the 1980s as a research tool for studying pigmentation biology.
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
| Property | Value | Notes |
|---|---|---|
| Compound class | Synthetic cyclic heptapeptide | Alpha-MSH analogue containing a D-phenylalanine residue |
| Molecular formula | C50H69N15O9 | Average molecular mass approximately 1024.2 g/mol |
| Appearance | White to off-white lyophilised powder | Normally supplied as a freeze-dried solid in a sealed vial |
| Solubility | Freely soluble in water and polar solvents | Dissolves readily in aqueous buffers and in alcohol-water mixtures |
| Receptor targets | MC1R, MC3R, MC4R, MC5R | Acts as a non-selective melanocortin receptor agonist |
Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, the naturally occurring peptide involved in pigmentation signalling. Its sequence is conventionally written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, with a lactam bridge joining the aspartate side chain to the lysine side chain. The empirical formula is C50H69N15O9 and the monoisotopic mass lies near 1023.5 daltons. N-terminal acetylation and the D-configured phenylalanine both increase resistance to enzymatic breakdown compared with the parent hormone.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.
Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.
=== Pregnancy === In pregnancy, the vulva and vagina take on a bluish coloring due to venous congestion. This appears between the eighth and twelfth week and continues to darken as the pregnancy continues. Estrogen is produced in large quantities during pregnancy and this causes the vulva to become enlarged. The vaginal opening and the vagina are also enlarged. After childbirth, a vaginal discharge known as lochia is produced and continues for about ten days.
== External operations == The Selous Scouts were involved in the Rhodesian military's attacks on insurgents and their bases in neighbouring countries, often known as external operations (or 'externals' for short). These operations became frequent from 1976. The unit's role in external operations included intelligence collection and directly attacking insurgents. In the intelligence gathering role, the Selous Scouts' Reconnaissance Troop conducted one or two man long-range reconnaissance patrols to locate or gather information on insurgent bases in Mozambique and Zambia. During direct attacks the Selous Scouts often impersonated soldiers of the country they were operating in. The Selous Scouts operated in eastern Botswana. This included fighting small actions against insurgents and a raid in which ZAPU leaders were captured in Francistown. The Selous Scouts also used pseudo tactics to collect intelligence in Francistown. Operation Long John was launched on 25 June 1976, against two guerilla bases located in Mozambique. This operation used 'flying column' tactics for the first time, which involved six vehicles manned by the Selous Scouts attacking the bases. Large quantities of munitions were destroyed, but few casualties were inflicted. On 9 August 1976, the Selous Scouts carried out Operation Eland, a raid on a ZANLA and FRELIMO controlled refugee camp at Nyadzonia in Mozambique. The Selous Scouts, who were mostly black and disguised in FRELIMO uniforms, included former Portuguese Army soldiers and a former ZANLA commander.
=== Antimicrobial peptides and biomembranes === Mechler's research on biomolecular interactions has focused on lipid membranes, their phase and domain dynamics, and membrane disruption by antimicrobial peptides. He utilized spectroscopic imaging and near-field microscopy to show that cholesterol-rich domains in bilayer membranes form optimally at a 15:85 lipid-cholesterol ratio, with specific domain separation occurring at lower concentrations. Additionally, he found that the structure of supported phospholipid bilayers varies with liposome size, composition, and substrate, as shown by quartz crystal microbalance and atomic force microscopy. Working with Imad Younus Hasan, Mechler employed QCM-based measurements to show cholesterol induces phase separation in single bilayer lipid membranes and demonstrated that partially suspended DMPC-based bilayer membranes can form on functionalized gold surfaces in a way that allows natural membrane movement, providing a truly Biomimetic platform for membrane studies and protein insertion. They also mapped thermodynamic phase transitions of lipid membranes, through nanoviscosity measurements, in single bilayer lipid membranes, revealing that domain separation occurs only in planar membranes and that phase transitions are due to the breaking of van der Waals interactions. Using quartz crystal microbalance and atomic force microscopy, Mechler and his research group investigated how specific antimicrobial peptides secreted by insects such as honeybees and amphibians such as Australian tree frogs disrupt bacterial membranes.
== Bibliography == Michel Demopoulos, directeur de publication, Le Cinéma grec [Greek Cinema], Paris, Centre Georges Pompidou, collection «cinéma/pluriel,» 1995, 263 pages, ISBN 2858508135. (in French) Vrasidas Karalis, A History of Greek Cinema, New York, New York and London, Continuum International Publishing Group, 2012, 344 pages, ISBN 978-1-4411-9447-3. Sylvie Rollet, directeur de publication (préface: Theo Angelopoulos), Théorème 9: Théo Angelopoulos au fil du temps [Theo Angelopoulos over the Course of Time], Paris, Presses Sorbonne Nouvelle, 2007, 189 pages, ISBN 978-2-87854-372-8. (in French) Stéphane Sawas, «Grèce (1967–1974) – Les écrans grecs sous la dictature des colonels: la grande rupture,» [Greece (1967–1974) – Greek Screens Under the Dictatorship of the Colonels: The Great Break] dans Raphaël Muller et Thomas Wieder, directeurs de publication, Cinéma et régimes autoritaires au xxe siècle: Écrans sous influence [Cinema and Authoritarian Regimes in the Twentieth Century: Screens Under Influence], Paris, Éditions École Normale Supérieure rue d'Ulm et Presses Universitaires de France, collection «Les rencontres de Normale Sup',» 2008, 285 pages, ISBN 978-2-13-055749-4.
Sources: en.wikipedia.org
Key State Department personnel grew increasingly frustrated with and suspicious of the Soviets as the war drew to a close. Averell Harriman, US Ambassador in Moscow, once a "confirmed optimist" regarding US–Soviet relations, was disillusioned by what he saw as the Soviet betrayal of the 1944 Warsaw Uprising as well as by violations of the February 1945 Yalta Agreement concerning Poland. Harriman would later have a significant influence in forming Truman's views on the Soviet Union. In February 1946, the US State Department asked George F. Kennan, then at the US Embassy in Moscow, why the Russians opposed the creation of the World Bank and the International Monetary Fund. He responded with a wide-ranging analysis of Russian policy now called the Long Telegram:
=== Gastrointestinal === CCK is synthesized and released by enteroendocrine cells in the mucosal lining of the small intestine (mostly in the duodenum and jejunum), called I cells, neurons of the enteric nervous system, and neurons in the brain. It is released rapidly into the circulation in response to a meal. The greatest stimulator of CCK release is the presence of fatty acids and/or certain amino acids in the chyme entering the duodenum. In addition, release of CCK is stimulated by monitor peptide (released by pancreatic acinar cells), CCK-releasing protein (via paracrine signalling mediated by enterocytes in the gastric and intestinal mucosa), and acetylcholine (released by the parasympathetic nerve fibers of the vagus nerve). Once in the circulatory system, CCK has a relatively short half-life.
=== Cephadroxil === Cefadroxil is an antibiotic. Bristol-Myers Squibb (BMS) patented the "Bouzard form" under US Patent No. 4,504,657 ('657) in 1985. The patenting took 6 years due to disputes about polymorphs. An earlier patent (US Patent No. 3,781,282) covered a different form, the "Micetich form". Attempts to replicate the Micetich form according to Example 19 in the '282 patent consistently yielded the Bouzard form, leading to challenges that the '657 patent was already inherent in the '282 patent, thus invalidated by prior art. BMS argued that the prevalence of the Bouzard form in manufacturing facilities led to unintentional seeding. Experimental tests of the seeding theory were ambiguous, but eventually the patent was granted. Later, Zenith Laboratories marketed a cefadroxil hemihydrate. BMS sued for "gastrointestinal infringement", claiming it converted to the patented Bouzard form in the stomach. The case hinged on the interpretation of X-ray diffraction data, with BMS arguing it demonstrated the presence of the Bouzard form in patients who ingested Zenith's product. However, the court sided with Zenith.
Carbon monoxide bonds to transition metals using "synergistic pi* back-bonding". The M–C bonding has three components, giving rise to a partial triple bond. A sigma (σ) bond arises from overlap of the nonbonding (or weakly anti-bonding) sp-hybridized electron pair on carbon with a blend of d-, s-, and p-orbitals on the metal. A pair of pi (π) bonds arises from overlap of filled d-orbitals on the metal with a pair of π*-antibonding orbitals projecting from the carbon atom of the CO. The latter kind of binding requires that the metal have d-electrons, and that the metal be in a relatively low oxidation state (0 or +1) which makes the back-donation of electron density favorable. As electrons from the metal fill the π-antibonding orbital of CO, they weaken the carbon–oxygen bond compared with free carbon monoxide, while the metal–carbon bond is strengthened. Because of the multiple bond character of the M–CO linkage, the distance between the metal and carbon atom is relatively short, often less than 1.8 Å, about 0.2 Å shorter than a metal–alkyl bond. The M-CO and MC-O distance are sensitive to other ligands on the metal. Illustrative of these effects are the following data for Mo-C and C-O distances in Mo(CO)6 and Mo(CO)3(4-methylpyridine)3: 2.06 vs 1.90 and 1.11 vs 1.18 Å.
=== Recreational use === It was said in the mid-1970s that use of nutmeg for recreational purposes was almost exclusively confined to the United States. It was said to be sought as an alternative to other preferred hallucinogens such as LSD and cannabis. The drug has frequently been used by incarcerated people in prisons. This has led to availability of nutmeg in prison kitchens being restricted.
Sources: en.wikipedia.org
=== Medical informatics, AI, and multimodal modeling === Several studies have focused on data standards and artificial intelligence using Truveta data. A 2023 preprint titled Truveta Mapper: A Zero-shot Ontology Alignment Framework presented a methodology for aligning biomedical ontologies using zero-shot learning, as a tool that could support data interoperability for health systems. A 2025 study published in Studies in Health Technology and Informatics explored structured large language model (LLM) augmentation for clinical information extraction, assessing its performance and potential for healthcare data analysis. In 2025, a study in Radiology Advances developed "XComposition", a multimodal deep-learning model that uses chest radiographs and clinical data to estimate body composition, as an application of large health-system data for medical imaging research.
=== Displacement === After the entire sample is loaded, the feed is switched to the displacer, chosen to have higher affinity than any sample component. The displacer forms a sharp-edged zone at the head of the column, pushing the other components downstream. Each sample component now acts as a displacer for the lower-affinity solutes, and the solutes sort themselves out into a series of contiguous bands (a "displacement train"), all moving downstream at the rate set by the displacer. The size and loading of the column are chosen to let this sorting process reach completion before the components reach the bottom of the column. The solutes appear at the bottom of the column as a series of contiguous zones, each consisting of one purified component, with the concentration within each individual zone effectively uniform.
=== Personal life === Flory was born in Sterling, Illinois, on June 19, 1910 to Ezra Flory and Martha Brumbaugh. His father worked as a clergyman-educator, and his mother was a school teacher. His ancestors were German Huguenots, who traced their roots back to Alsace. He first gained an interest in science from Carl W Holl, who was a chemistry professor at Manchester College. In 1936, he married Emily Catherine Tabor. They had three children together: Susan Springer, Melinda Groom and Paul John Flory, Jr. His first position was at DuPont with Wallace Carothers. He was posthumously inducted into the Alpha Chi Sigma Hall of Fame in 2002. Flory died on September 9, 1985, following a heart attack. His wife Emily died in 2006 aged 94.
A 2014 study suggests that bromine (in the form of bromide ion) is a necessary cofactor in the biosynthesis of collagen IV, making the element essential to basement membrane architecture and tissue development in animals. Nevertheless, no clear deprivation symptoms or syndromes have been documented in mammals. In other biological functions, bromine may be non-essential but still beneficial when it takes the place of chlorine. For example, in the presence of hydrogen peroxide, H2O2, formed by the eosinophil, and either chloride, iodide, thiocyanate, or bromide ions, eosinophil peroxidase provides a potent mechanism by which eosinophils kill multicellular parasites (such as the nematode worms involved in filariasis) and some bacteria (such as tuberculosis bacteria). Eosinophil peroxidase is a haloperoxidase that preferentially uses bromide over chloride for this purpose, generating hypobromite (hypobromous acid), although the use of chloride is possible.
Sources: en.wikipedia.org
No. It is a laboratory-made peptide, while the natural hormone is alpha-melanocyte-stimulating hormone, a longer peptide produced by the pituitary gland and by skin cells. Melanotan-2 mimics only a short active region of that hormone and contains non-natural residues such as D-phenylalanine.
No approved regulatory indication exists in major markets. An approval exists for a different peptide, afamelanotide, which is used for a rare photosensitivity disorder called erythropoietic protoporphyria. Melanotan-2 itself remains a research compound with no cleared clinical role.
Melanocortin-1 receptors on melanocytes are the receptor most closely linked to pigment production. The peptide is not selective, however, and also activates melanocortin-3, melanocortin-4, and melanocortin-5 receptors. That lack of selectivity is the usual explanation offered for both its range of observed effects and its off-target effects.
No. No major regulatory agency has granted a marketing authorisation for melanotan II as a medicine. Products sold under this name are generally presented as laboratory reagents and are not subject to the batch-release testing applied to approved drugs.